AVAHAveanna Healthcare Holdings...

Nasdaq aveanna.com


$ 5.71 $ 0.34 (6.27 %)    

Thursday, 05-Sep-2024 15:00:23 EDT
QQQ $ 459.86 $ 0.43 (0.09 %)
DIA $ 407.95 $ -1.96 (-0.48 %)
SPY $ 548.56 $ -1.34 (-0.24 %)
TLT $ 99.56 $ 0.56 (0.57 %)
GLD $ 232.35 $ 1.92 (0.83 %)
$ 5.76
$ 5.36
$ 5.69 x 100
-- x --
$ 5.30 - $ 5.76
$ 0.85 - $ 5.87
247,985
na
1.11B
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-29-2024 10-Q
2 05-09-2024 03-30-2024 10-Q
3 03-14-2024 12-30-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-10-2023 07-01-2023 10-Q
6 05-11-2023 04-01-2023 10-Q
7 03-16-2023 12-31-2022 10-K
8 11-15-2022 10-01-2022 10-Q
9 08-11-2022 07-02-2022 10-Q
10 05-11-2022 04-02-2022 10-Q
11 03-28-2022 01-01-2022 10-K
12 11-15-2021 10-02-2021 10-Q
13 08-11-2021 07-03-2021 10-Q
14 05-25-2021 04-03-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rbc-capital-maintains-sector-perform-on-aveanna-healthcare-hldgs-raises-price-target-to-5

RBC Capital analyst Ben Hendrix maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Sector Perform and raises the price ...

 deutsche-bank-maintains-buy-on-aveanna-healthcare-hldgs-raises-price-target-to-5

Deutsche Bank analyst Pito Chickering maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Buy and raises the price targe...

 ubs-maintains-sell-on-aveanna-healthcare-hldgs-raises-price-target-to-28

UBS analyst A.J. Rice maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Sell and raises the price target from $1.7 to ...

 aveanna-healthcare-holdings-expects-fy24-revenue-of-1985b-prior-1970b-vs-1979b-est

Revised Full Year 2024 Guidance The following is our updated guidance reflecting our current expectations for revenue and Adju...

 aveanna-healthcare-hldgs-q2-2024-adj-eps-001-beats-002-estimate-sales-504958m-beat-493360m-estimate

Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate...

 aveanna-healthcare-revises-fy24-revenue-forecast-to-greater-than-197b-est-1975b-updated-from-prior-guidance-of-196m-198b

djusted EBITDA of greater than $150 million, updated from prior guidance of Adjusted EBITDA between $146 million and $150 million

 aveanna-healthcare-hldgs-q1-2024-adj-eps-003-beats-005-estimate-sales-490653m-beat-483976m-estimate

Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate...

 deutsche-bank-maintains-buy-on-aveanna-healthcare-hldgs-raises-price-target-to-3

Deutsche Bank analyst Pito Chickering maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Buy and raises the price targe...

 aveanna-healthcare-hldgs-q4-adj-eps-002-inline-sales-47884m-beat-46740m-estimate

Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported adjusted quarterly losses of $(0.02) per share which met the analyst consensus ...

 earnings-scheduled-for-march-14-2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

 jp-morgan-downgrades-aveanna-healthcare-hldgs-to-underweight

JP Morgan analyst Lisa Gill downgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Neutral to Underweight.

 earnings-scheduled-for-november-9-2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

 aveanna-healthcare-raises-fy2023-sales-outlook-from-185b---186b-to-187b---188b-vs-186b-est

Revised Full Year 2023 Guidance   The following is our updated guidance reflecting our current expectations for revenue and A...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION